Study of Litfulo for severe alopecia areata in routine care
Part of Skin clinical trials.
This study looks at how well Litfulo capsules work for people with severe alopecia areata in everyday medical practice. It is for adults and teens aged 12 or older who are starting Litfulo as part of their normal care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe alopecia areata (a condition that causes patchy or total hair loss).
- Your doctor has decided to start you on Litfulo capsules for your alopecia areata, as it is approved for this use.
- You are 12 years old or older.
- If you are under 18, your parent or legal guardian agrees to the study and signs a consent form. You may also sign if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
This study tests an oral medication (SYHX1901) for severe alopecia areata, a condition where the immune system attacks hair follicles, causing significant hair loss. If you qualify, you may receive the study drug to see if it helps regrow hair and improve your condition.
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
This trial tests an oral medication called NXC-736 for people with moderate to severe alopecia areata. It aims to see if the drug is safe and can help regrow hair.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This trial tests a new medication called LAD603 for people with severe to very severe alopecia areata, a condition causing significant hair loss. It aims to see if the drug can help regrow hair.
Hear when a new Severe Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.